Abstract
Advanced biomaterials are required with enhanced antibacterial and anticancer activities to obtain desirable biocompatibility during and after scaffold implantation in tissue engineering. Here, we report the development of a nanosystem by the hydrothermal method using different zinc (Zn) amounts and reduced graphene oxide (GO). Arabinoxylan, the nanosystem (Zn@rGO), and nanohydroxyapatite polymeric nanocomposites ARX-g-(Zn@rGO)/HAp were prepared by the free radical polymerization method, and porous bioactive scaffolds were fabricated via the freeze-drying technique. The structural, morphological, and elemental analyses of the bioactive scaffolds were conducted using Fourier transform infrared spectroscopy, X-ray diffraction, scanning electron microscopy, and energy-dispersive X-ray analysis. The wetting behavior was studied by a water contact meter and swelling in aqueous and phosphate-buffered saline solutions at 37 °C. The degradation was also studied in the phosphate-buffered saline solution at 37 °C. The increase in Zn content increased the pore size, and hydrophobic behavior shifted to hydrophilic (AGZ-1 = 131.40° at 0 s and 120.60° at 10 s to AGZ-1 = 81.30° at 0 s and 69.20° at 10 s) with the increase in contact time. Maximum swelling was observed in deionized water (AGZ-1 = 52.87%, AGZ-4 = 90.20%), followed by phosphate-buffered saline (PBS; AGZ-1 = 44.80%, AGZ-4 = 67.90%) and electrolyte (AGZ-1 = 32.40%, AGZ-4 = 63.47%), and biodegradation in PBS media increased (AGZ-1 = 36.80%, AGZ-4 = 55.92%). Antimicrobial activities against severe infection-causing pathogens and antitumor activity against U87 cell lines showed exceptional results. Cell viability and cell proliferation studies were conducted against preosteoblast cell lines, and increased cell viability and proliferation were observed from AGZ-1 to AGZ-4. Antimicrobial and anticancer activities were enhanced with the increase of Zn content in the Zn@rGO system. The bioactive scaffolds with different formulations could be potential biomaterials to treat and regenerate defected bone tissue.